当前位置: 首页 > 期刊 > 《齐齐哈尔医学院学报》 > 2006年第17期
编号:11416247
冬虫夏草制剂对恶性肿瘤患者化疗后T细胞亚群的影响
http://www.100md.com 《齐齐哈尔医学院学报》 2006年第17期
冬虫夏草制剂,肿瘤,T淋巴细胞,,冬虫夏草制剂,肿瘤,T淋巴细胞,1对象与方法,2结果,3讨论,参考文献
     【摘要】 目的 观察冬虫夏草制剂对肿瘤患者化疗后T细胞亚群的影响。方法 对68例恶性肿瘤患者随机分为两组,一组冬虫夏草制剂加化疗,另一组单纯化疗组。结果 冬虫夏草制剂加化疗组化疗后,CD3、CD4细胞比例,CD4/CD8比值较化疗前明显增加。结论 冬虫夏草制剂可以改善化疗所致的免疫功能低下。

    【关键词】 冬虫夏草制剂 肿瘤 T淋巴细胞

    Effect of Cordyceps to Tlymphocyte Subsets after Malignant Tumor Chemotherapy

    Sun Yan,et al.

    (Department of Medical Technology,Qiqihar Medical College,Heilongjiang,161042)

    【Abstract】 Objective To observe the effect of Cordyceps to T lymphocyte subsets of tumor patients treated with chemotherapy.Methods 68 malignant tumor patients were divided into two groups randomly.One group were treated with chemotherapy,at the same time Cordyceps were given.The other were supplied with chemotherapy only.Results Compared to using chemotherapy alon,the ratio of CD3/CD4 and CD4/CD8 of the group given Cordyceps additionally increased significantly.Conclusions Cordyceps can improve immunological hypofunction state resulted from chemotherapy.

    【Key words】 Cordyceps Tumor T lymphocyte subsets

    冬虫夏草﹝Cordycepe Sinensis(berk),Sace,CS﹞为麦菌科真菌 ......

您现在查看是摘要页,全文长 4552 字符